Pular para o conteúdo
Tumor de plasmócitos
ORPHA:98282DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Digestivo

Uma multiplicação descontrolada de plasmócitos idênticos, que são células que produzem imunoglobulinas (também chamadas de anticorpos). Essa categoria inclui o mieloma múltiplo, a leucemia de plasmócitos, o plasmocitoma, a doença de deposição de imunoglobulina monoclonal e a gamopatia monoclonal de significado incerto.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

O tumor de plasmócitos é um conjunto de doenças marcado pela multiplicação excessiva de plasmócitos, células responsáveis pela defesa e produção de anticorpos. A condição costuma provocar dores ósseas intensas decorrentes de osteoporose e fraturas espontâneas, além de cansaço decorrente de anemia. O funcionamento dos rins também pode ser afetado, gerando lesão renal e acúmulo excessivo de cálcio no sangue. Embora a doença não conte com um protocolo clínico oficial de doença rara no Ministério da Saúde, o paciente pode ser avaliado e acompanhado na rede de atenção especializada.

📋
Informacoes curadas por IA — podem conter imprecisoes

Uma multiplicação descontrolada de plasmócitos idênticos, que são células que produzem imunoglobulinas (também chamadas de anticorpos). Essa categoria inclui o mieloma múltiplo, a leucemia de plasmócitos, o plasmocitoma, a doença de deposição de imunoglobulina monoclonal e a gamopatia monoclonal de significado incerto.

Pesquisas ativas
94 ensaios
700 total registrados no ClinicalTrials.gov
Publicações científicas
336 artigos
Último publicado: 2026 Apr 17
🏥
SUS: Sem cobertura SUSScore: 5%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
9 sintomas
🩸
Sangue
7 sintomas
🫃
Digestivo
6 sintomas
🫘
Rins
5 sintomas
🧬
Pele e cabelo
2 sintomas
📏
Crescimento
2 sintomas

+ 24 sintomas em outras categorias

Características mais comuns

—
Anormalidade do intestino delgado
—
Erupção cutânea
—
Morfologia anormal do palato
—
Anemia hemolítica autoimune
—
Atraso de crescimento
—
Dor abdominal
62sintomas
Sem dados (62)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 62 características clínicas mais associadas, ordenadas por frequência.

Anormalidade do intestino delgadoAbnormality of the small intestine
Morfologia anormal do palatoAbnormal palate morphology
Anemia hemolítica autoimuneAutoimmune hemolytic anemia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico336PubMed
Últimos 10 anos110publicações
Pico202418 papers
Linha do tempo
2026Hoje · 2026🧪 1975Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição.

CCND1G1/S-specific cyclin-D1Candidate gene tested inRestrito
VIAS BIOLÓGICAS (9)
Cyclin D associated events in G1PTK6 Regulates Cell CycleSCF(Skp2)-mediated degradation of p27/p21SPOP-mediated proteasomal degradation of PD-L1(CD274)Transcriptional Regulation by VENTX
OUTRAS DOENÇAS (5)
B-cell chronic lymphocytic leukemiaplasma cell myelomavon Hippel-Lindau diseasemantle cell lymphoma
HGNC:1582UniProt:P24385
LIG4DNA ligase 4Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Nonhomologous End-Joining (NHEJ)2-LTR circle formation
MECANISMO DE DOENÇA

LIG4 syndrome

Characterized by immunodeficiency and developmental and growth delay. Patients display unusual facial features, microcephaly, growth and/or developmental delay, pancytopenia, and various skin abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
17.9 TPM
Cérebro - Hemisfério cerebelar
17.6 TPM
Cerebelo
16.5 TPM
Linfócitos
15.0 TPM
Testículo
13.6 TPM
OUTRAS DOENÇAS (4)
DNA ligase IV deficiencyDubowitz syndromeOmenn syndromeplasma cell myeloma
HGNC:6601UniProt:P49917

Variantes genéticas (ClinVar)

274 variantes patogênicas registradas no ClinVar.

🧬 CCND1: GRCh37/hg19 11q12.2-13.5(chr11:59923608-76272324)x3 ()
🧬 CCND1: NC_000011.9:g.(?_64973914)_(70052579_?)dup ()
🧬 CCND1: GRCh37/hg19 11p13-q25(chr11:32799481-134938470)x3 ()
🧬 CCND1: GRCh37/hg19 11q13.3-13.4(chr11:69214835-70821137)x1 ()
🧬 CCND1: Single allele ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado1
3Fase 311
2Fase 235
1Fase 117
·Pré-clínico36
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 100 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Tumor de plasmócitos

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 31 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

55 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT06152575 · MagnetisMM-32: A Study to Learn About the Study Medicine Cal…Recrutando
PHASE3🇧🇷 Brasil · 🇦🇷 Argentina · 🇦🇺 Austrália +24
NCT07714044 · Rutgers University Study of the Genetics of Blood CancersRecrutando
🇺🇸 Estados Unidos
NCT07665307 · Delayed Toxicities Post-CAR-TRecrutando
🇺🇸 Estados Unidos
NCT07649525 · Personalising Treatment for Myeloma Patients Based on Initia…Recrutando
PHASE3🇬🇧 Reino Unido
NCT06870760 · Pre-malignant States to Hematologic Malignancies in Firefigh…Recrutando
🇺🇸 Estados Unidos
NCT06971848 · Evaluation of Skin Tests in Biotherapy AllergiesRecrutando
NA🇫🇷 França
NCT07586709 · In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/R…Recrutando
EARLY_PHASE1🇨🇳 China
NCT07519187 · CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Ref…Recrutando
EARLY_PHASE1🇨🇳 China
NCT07426484 · Cosibelimab for CSCC in Patients With Kidney Transplant or H…Recrutando
PHASE4🇺🇸 Estados Unidos
NCT07777406 · Real-life Study on the Use of Allogeneic Hematopoietic Stem …Recrutando
🇮🇹 Itália
NCT07529782 · Study to Assess Safety and Efficacy of HDP-101 in Chinese Pa…Recrutando
PHASE1🇨🇳 China
NCT07319897 · 68Ga-BCMA PET/CT in Multiple MyelomaRecrutando
PHASE2, PHASE3🇨🇳 China
NCT07075510 · Subcutaneous Daratumumab Administration in the Thigh Vs Abdo…Recrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT06487247 · HEME Home Transfusion ProgramRecrutando
NA🇺🇸 Estados Unidos
NCT07390071 · Multimodal Telerehabilitation in Patients Undergoing CAR-T C…Recrutando
NA🇺🇸 Estados Unidos
NCT07106671 · A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in …Recrutando
PHASE2🇨🇳 China
NCT07052916 · A Music Therapy Study for Blood Cancer Survivors With Cognit…Recrutando
NA🇺🇸 Estados Unidos
NCT06947083 · Elranatamab Post Cilta-cel in Patients With Clinical High Ri…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT07202078 · Role of Antibiotic Therapy or Immunoglobulin On iNfections i…Recrutando
PHASE2, PHASE3🇦🇺 Austrália
NCT07202091 · Role of Antibiotic Therapy or Immunoglobulin On iNfections i…Recrutando
PHASE2, PHASE3🇦🇺 Austrália
NCT07202052 · Role of Antibiotic Therapy or Immunoglobulin On iNfections i…Recrutando
PHASE2, PHASE3🇦🇺 Austrália
NCT07032129 · Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients Wit…Recrutando
PHASE1, PHASE2🇨🇳 China
NCT07202065 · Role of Antibiotic Therapy or Immunoglobulin On iNfections i…Recrutando
PHASE2, PHASE3🇦🇺 Austrália
NCT06863584 · SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II T…Recrutando
PHASE2🇨🇳 China
NCT05745285 · Leukemia and Lymphoma Society (LLS) Services Impact on Outco…Recrutando
NA🇺🇸 Estados Unidos
NCT06518551 · Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMMRecrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT06313502 · High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell …Recrutando
PHASE1🇺🇸 Estados Unidos
NCT06430736 · PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizum…Recrutando
PHASE2🇨🇭 Suíça
NCT06271252 · A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Sub…Recrutando
PHASE1🇺🇸 Estados Unidos
NCT06066359 · Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 T…Recrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT06132711 · Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapse…Recrutando
PHASE1, PHASE2🇨🇳 China
NCT05597345 · Selinexor for the Treatment of Intermediate and High-Risk Sm…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT06644443 · BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple…Recrutando
PHASE1, PHASE2🇨🇳 China
NCT05573802 · A Study to Investigate Safety and Clinical Activity of Belan…Recrutando
PHASE1, PHASE2Greece
NCT06236373 · The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emi…Recrutando
🇮🇹 Itália
NCT06760052 · Longitudinal Data Registry of Plasma Cell DyscrasiaRecrutando
🇨🇳 China
NCT05651932 · A Study of an MMSET Inhibitor in Patients With Relapsed and …Recrutando
PHASE1🇨🇦 Canadá · 🇫🇷 França · 🇪🇸 Espanha +1
NCT03633955 · Pilot Imaging Study of LeukemiaRecrutando
PHASE1🇺🇸 Estados Unidos
NCT04935684 · Faecal Microbiota Transplantation After Allogeneic Stem Cell…Recrutando
PHASE2🇫🇷 França
NCT05678621 · Role of Antibiotic Therapy or Immunoglobulin On iNfections i…Recrutando
PHASE2, PHASE3🇦🇺 Austrália
NCT06250595 · European Rare Blood Disorders Platform (ENROL)Recrutando
🇪🇸 Espanha
NCT05055063 · A Phase 1 With Extension Cohort, Single Arm, Single Center, …Recrutando
PHASE1🇺🇸 Estados Unidos
NCT05248633 · Chemotherapy Combined With Radiotherapy Versus Radiotherapy …Recrutando
PHASE2🇨🇳 China
NCT04879043 · Study to Assess Safety of HDP-101 in Patients With Relapsed …Recrutando
PHASE1, PHASE2🇩🇪 Alemanha · Hungary · 🇵🇱 Polônia +2
NCT04776330 · a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therap…Recrutando
PHASE1, PHASE2🇨🇳 China
NCT04268199 · A Multicentre, Non-Blinded Study Exploring Self-Administrati…Recrutando
PHASE2🇨🇦 Canadá
NCT04271644 · BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Mul…Recrutando
PHASE1, PHASE2🇨🇳 China
NCT03807128 · MYeloma Resistance And Clonal EvolutionRecrutando
🇫🇷 França
NCT03702309 · Liquid Biopsy Evaluation and Repository Development at Princ…Recrutando
🇨🇦 Canadá
NCT03131531 · Bergamo Lymphoid Cancer RegistryRecrutando
🇮🇹 Itália
NCT01137825 · Registry of Older Patients With CancerRecrutando
🇺🇸 Estados Unidos
NCT01137643 · Tissue, Blood, and Body Fluid Sample Collection From Patient…Recrutando
🇺🇸 Estados Unidos
NCT00106925 · Long-term Evaluation and Follow-up Care of Patients Treated …Recrutando
🇺🇸 Estados Unidos
NCT05775224 · ASH Research Collaborative Data HubPor convite
🇺🇸 Estados Unidos
NCT07410403 · AI-Based Fine Morphological Subtyping of Myeloma Single Cell…Por convite
🇨🇳 China

Outros ensaios clínicos

700 ensaios clínicos encontrados, 94 ativos.

Distribuição por fase
NCT07600151 · Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple MyelomaEm breve
PHASE1, PHASE2🇩🇪 Alemanha
NCT07532473 · REal World MAIA UK OutcomEsEm breve
🇬🇧 Reino Unido
NCT07831122 · Study of Belantamab Mafodotin, Cevostamab, Pomalidomide for …Em breve
PHASE1🇨🇦 Canadá
NCT07751471 · BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnos…Em breve
PHASE2🇨🇳 China
NCT07354555 · Multiple Myeloma Extramedulary Disease Samples FFPEEm breve
🇫🇷 França
NCT06986434 · CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell N…Em breve
EARLY_PHASE1🇨🇳 China
NCT07077330 · CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell N…Em breve
EARLY_PHASE1🇨🇳 China
NCT06450821 · PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Che…Em breve
NA🇬🇧 Reino Unido
NCT06330896 · Disease Characteristics and Treatment Response in Plasma Cel…Em breve
NCT06286215 · Registry of Patients With Plasma Cell DisordersEm breve
NCT05581875 · A Study to Investigate the Safety and Clinical Activity of B…Em breve
PHASE1, PHASE2
NCT05353907 · Dual-Energy Computed Tomography for Improving Imaging Assess…Em breve
NCT02952508 · Study of Iopofosine I-131 (CLR 131) in Select B-Cell Maligna…Ativo
PHASE2🇧🇷 Brasil · 🇦🇺 Austrália · 🇨🇿 Tchéquia +8
NCT06523699 · Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor …Ativo
PHASE1🇺🇸 Estados Unidos
NCT06944119 · Assesment of the Immune Response to RSV Vaccine in Patients …Ativo
🇮🇱 Israel
NCT05889221 · Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bo…Ativo
NA🇫🇷 França
NCT07809594 · CS1-Targeted CAR-T Cells for Relapsed/Refractory Multiple My…Ativo
PHASE1🇨🇳 China
NCT05336383 · Phase II Study of Salvage Radiation Treatment After B-cell M…Ativo
PHASE2🇺🇸 Estados Unidos
NCT04891809 · Isatuximab in Combination With Rd Compared to Rd in Elderly …Ativo
PHASE2🇦🇹 Áustria · Greece · Serbia
NCT04782687 · Study of Selinexor Plus DRd for Newly Diagnosed Multiple Mye…Ativo
PHASE2🇺🇸 Estados Unidos
NCT04751877 · Multicenter Open Label Phase 3 Study of Isatuximab Plus Lena…Ativo
PHASE3🇫🇷 França
NCT04680468 · Study of Belantamab Mafodotin as Pre- and Post-autologous St…Ativo
PHASE2🇺🇸 Estados Unidos
NCT04822337 · Study of Carfilzomib, Lenalidomide, Dexamethasone and Belant…Ativo
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT04649359 · MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy…Ativo
PHASE2🇦🇺 Austrália · 🇨🇦 Canadá · 🇫🇷 França +5
NCT04142372 · Tissue Microarray of Hematological MalignanciesAtivo
🇫🇮 Finlândia
NCT04155749 · Study of Anitocabtagene-autoleucel in Participants With Rela…Ativo
PHASE1🇺🇸 Estados Unidos
NCT03500445 · Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexameth…Ativo
PHASE2🇺🇸 Estados Unidos
NCT03289299 · Aggressive Smoldering Curative Approach Evaluating Novel The…Ativo
PHASE2🇺🇸 Estados Unidos
NCT03314636 · Intensified Treatment With Carfilzomib in Myeloma Patients S…Ativo
PHASE2🇩🇰 Dinamarca · 🇳🇴 Noruega · 🇸🇪 Suécia
NCT03162536 · A Study of Nemtabrutinib (MK-1026) in Participants With Rela…Ativo
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT02886065 · A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- L…Ativo
PHASE1🇺🇸 Estados Unidos
NCT02899052 · Study of Venetoclax in Combination With Carfilzomib and Dexa…Ativo
PHASE2🇦🇺 Austrália · Hungary · Puerto Rico +2
NCT01269593 · PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Stu…Ativo
EARLY_PHASE1🇺🇸 Estados Unidos
NCT01208662 · Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone …Ativo
PHASE3🇺🇸 Estados Unidos
NCT01177527 · Questionnaire and Tissue Banking For Multiple Myeloma, Walde…Ativo
🇺🇸 Estados Unidos
NCT00935090 · 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients Wi…Ativo
🇺🇸 Estados Unidos
NCT00881920 · Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-ce…Ativo
PHASE1🇺🇸 Estados Unidos
NCT00871013 · Trial for Patients Not Qualifying for TT4 and TT5 Protocols …Ativo
PHASE2🇺🇸 Estados Unidos
NCT00544115 · Donor Peripheral Stem Cell Transplant in Treating Patients W…Ativo
PHASE2
NCT01023308 · Panobinostat or Placebo With Bortezomib and Dexamethasone in…Concluído
PHASE3🇧🇷 Brasil · 🇦🇷 Argentina · 🇦🇺 Austrália +31
NCT06610045 · The Burden of Multiple Myeloma on Patients and Caregivers Qu…Concluído
🇨🇦 Canadá
NCT05831787 · COVID19 OutcomeS in Myeloma and the Impact of VaCcinesConcluído
🇺🇸 Estados Unidos
NCT06504524 · A Study to Compare the Effects of Elranatamab (PF 06863135) …Concluído
🇩🇪 Alemanha · 🇺🇸 Estados Unidos
NCT05932290 · A Study to Learn About the Effectiveness of the Medicine Cal…Concluído
🇺🇸 Estados Unidos
NCT05763563 · Exercise Prehabilitation Among Older Patients With Hematolog…Concluído
NA🇺🇸 Estados Unidos
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
113 papers (10 anos)
#1

Pneumocystis jirovecii infection in autologous hematopoietic stem cell transplantation.

Leukemia & lymphoma2026 Mar

Pneumocystis jirovecii pneumonia (PJP) after autologous stem cell transplantation (ASCT) remains insufficiently characterized. We retrospectively analyzed 304 ASCT recipients (2005-2024) at a single center (B-cell lymphoma n = 138; plasma cell tumor n = 126). Fourteen patients (4.6%) developed PJP at a median of 143 days (86-286) post-ASCT; none were on prophylaxis at diagnosis. The 1-year cumulative incidence was 5.2% overall, and varied by disease: 24% in follicular lymphoma (FL), 5.9% in other B-cell lymphomas, 1.9% in plasma cell tumor, and 0% in T-cell lymphomas. Prior rituximab exposure (HR 6.75; 95% CI 1.50-30.2) and FL diagnosis (HR 7.26; 95% CI 2.51-20.9) were associated with higher risk; age, purine analogs, lymphocyte count, globulin/IgG, and conditioning were not. No death was directly attributable to PJP. These data suggest, diagnosis-dependent risk after ASCT; prophylaxis may be considered for rituximab-treated patients, especially FL, while the optimal duration warrants further study.

#2

Conjunctival plasmacytoma: A case study.

Archivos de la Sociedad Espanola de Oftalmologia2026 Feb

Plasmacytomas are localized collections of monoclonal plasma cells. This is a 48-year-old female patient of mixed race, with no significant medical history, with a soft, painless tumor adhered to the sclera, in the bulbar conjunctiva and inferior temporal fornix. The method used was the presentation of a clinical case. The tumor was excised with pathological analysis and immunohistochemical study confirming the diagnosis of conjunctival plasmacytoma. Postoperative follow-up was uneventful. Extraosseous plasma cell tumors located in the eye are rare and difficult to diagnose because they present a wide range of clinical differentiation.

#3

Intramuscular enhancing masses: Late relapse of multiple myeloma mimicking hematoma in trauma setting.

Radiology case reports2026 Feb

Extramedullary disease (EMD) is an uncommon and aggressive form of multiple myeloma, especially when localized to intramuscular locations. We present a case of a 45-year-old man with a history of IgG multiple myeloma (MM), who underwent allogeneic bone marrow transplantation and had been in clinical remission for more than a decade. He presented acutely after trauma with computed tomography (CT) revealed several enhancing masses in bilateral psoas, right obturator internus, right adductors and left sartorius muscles, which were initially misinterpreted as intramuscular hematomas. These masses remained stable on follow-up imaging, raising concern for underlying undiagnosed soft tissue tumors. Biopsy of one of the masses demonstrated a plasma cell tumor, and further evaluation confirmed relapse of multiple myeloma. Additionally, the largest mass in the left psoas exhibited peripheral calcification-an unusual imaging characteristic of extra ossous myeloma. Despite imaging following trauma, the presence of intramuscular masses in patients with history of MM should raise a high degree of clinical suspicion for EMD. Recognition of this diagnostic pitfall can help avoid delay diagnosis and inappropriate management.

#4

Ethmoid tumors in free-ranging white-tailed deer (Odocoileus virginianus).

Veterinary pathology2026 Jan

This report describes a series of ethmoid tumors in 6, free-ranging white-tailed deer (Odocoileus virginianus; WTD) in southwest to central Texas, which included 4 plasma cell tumors, 1 adenosquamous carcinoma, and 1 adenocarcinoma. The plasma cell tumors had a distinctive presentation with unilateral to bilateral facial masses located rostromedial to the eyes that were smooth and fluctuant. Upon dissection, these preorbital facial masses consisted of multiloculated, mucus-filled, cystic pockets with 2 having partial extension of the ethmoid tumors into the external facial masses. The 2 carcinomas were larger, unilateral, solid facial masses. All tumors caused extensive destruction of the ethmoid region with the carcinomas being paler, firmer, and more invasive into surrounding areas compared with the plasma cell tumors. Ancillary testing did not reveal an underlying infectious cause, although these reports of multiple WTD across a localized region suggest a possible infectious, environmental, or other shared stimulus.

#5

Case Report: Ultrasonographic and computed tomographic features of presumed gastric plasmacytoma (plasma cell tumor) with ulceration in two dogs.

Frontiers in veterinary science2025

Gastric plasmacytoma is rare in dogs, with only four previous reports providing limited descriptions of abdominal ultrasound (AUS) and computed tomography (CT) findings. This study presents the AUS and CT imaging features of two histopathologically suspected gastric plasmacytomas. Combining the four previous and two new cases, these tumors predominantly occurred in the greater curvature and pyloric antrum as solitary round masses connected to the submucosal or transmural layers. Pre- and post-contrast tissue attenuation (Hounsfield unit; HU) differences exceeded 40, with variable AUS echogenicity and echotexture. Imaging features may resemble those of spindle cell tumors, requiring histological and immunohistochemical examinations for definitive diagnosis.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC100 artigos no totalmostrando 109

2026

Pneumocystis jirovecii infection in autologous hematopoietic stem cell transplantation.

Leukemia & lymphoma
2026

Conjunctival plasmacytoma: A case study.

Archivos de la Sociedad Espanola de Oftalmologia
2026

Intramuscular enhancing masses: Late relapse of multiple myeloma mimicking hematoma in trauma setting.

Radiology case reports
2025

Prognostic value assessment and in vitro validation of mitochondria-ferroptosis-related genes in multiple myeloma.

Scientific reports
2025

Cyanidin-3-O-glucoside-mediated reduction of regulatory T cells: a therapeutic strategy for multiple myeloma.

BMC immunology
2025

[Multiple Myeloma Without Monoclonal Component: Nonsecretory and Non-Producing. Case Report and Review].

Revista medica de Chile
2025

Case Report: Ultrasonographic and computed tomographic features of presumed gastric plasmacytoma (plasma cell tumor) with ulceration in two dogs.

Frontiers in veterinary science
2025

Unexplained cardiac hypertrophy as a clue to plasma cell tumour: a case study.

American journal of translational research
2026

Ethmoid tumors in free-ranging white-tailed deer (Odocoileus virginianus).

Veterinary pathology
2025

Solitary Plasmacytomas: Current Status in 2025.

Hematology reports
2025

Case report and comprehensive literature review: A rare instance of solitary extramedullary plasmacytoma in the trachea.

Respiratory medicine case reports
2025

SPAG6 Promotes Multiple Myeloma Through Activation of the MAPK/ERK Signaling Pathway.

Frontiers in pharmacology
2025

First-line anti-BCMA CAR-T cell therapy in a fragile patient with biclonal gammopathy and giant plasma cell tumor multiple myeloma with multiple comorbidities: a case report.

Frontiers in immunology
2025

Review of tracheal neoplasia in dogs and cats (1961-2024).

Veterinary pathology
2025

Canine laryngotracheal plasma cell tumors: Ten cases and literature review.

Veterinary pathology
2025

[Risk stratified thromboprophylaxis and management of thrombotic events in plasma cell neoplasms].

Zhonghua yi xue za zhi
2025

Plasma Cell-Rich Lymphoid Neoplasm in an Endocervical Polyp of the Uterine Cervix in a Perimenopausal 52-Year-Old Woman.

HCA healthcare journal of medicine
2025

FIRST REPORT OF TUMORS IN GARDEN DORMICE (ELIOMYS QUERCINUS).

Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians
2024

[Analysis and reflections on the current status of diagnosis and treatment of marginal zone lymphoma].

Zhonghua yi xue za zhi
2024

A Rare Case of Solitary Endobronchial Plasmacytoma Presented With Complete Airway Obstruction: A Case Report.

Journal of investigative medicine high impact case reports
2024

2-Dimensional Operative Video for Staged Treatment of a Giant Plasma Cell Tumor: Principles for Neurosurgical Oncology During a Wartime Environment in Ukraine.

Operative neurosurgery (Hagerstown, Md.)
2024

Transendoscopic laser ablation of an esophageal plasma cell tumor in a cat.

JFMS open reports
2024

Acquired Bortezomib Resistance in Multiple Myeloma: From Mechanisms to Strategy.

Current treatment options in oncology
2024

Mandibular salivary gland plasma cell tumor in a dog.

Topics in companion animal medicine
2024

Changes in the immune microenvironment during plasma cell tumor development in the IL6Myc mouse model of human multiple myeloma.

Experimental cell research
2024

A "gullwing sign" on magnetic resonance imaging of extradural spinal tumors in dogs and cats allows prioritization of round cell neoplasia.

Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association
2024

Prognostic factors in Chinese patients with immunoglobulin light chain amyloidosis: a scoping review and meta-analysis.

Annals of medicine
2024

Interference with PLA2G16 promotes cell cycle arrest and apoptosis and inhibits the reprogramming of glucose metabolism in multiple myeloma cells by modulating the Hippo/YAP signaling pathway.

Anti-cancer drugs
2024

Refining the relationship between gut microbiota and common hematologic malignancies: insights from a bidirectional Mendelian randomization study.

Frontiers in cellular and infection microbiology
2024

Cutaneous plasmacytoma with Mott cell differentiation in a dog.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
2024

Successful Treatment of Refractory Orbital Plasmacytoma with Chimeric Antigen Receptor T Cell Therapy: A Case Report and Review of the Literature.

Ophthalmic plastic and reconstructive surgery
2024

Solitary Extramedullary Plasmacytoma of the Left Lower Eyelid: A Case Report and Review of Literature.

Cureus
2024

Solitary ovarian plasmacytoma: About a rare entity of extramedullary plasma cell tumor.

International journal of surgery case reports
2023

Outcomes in dogs undergoing surgical stabilization and non-stereotactic radiation therapy for axial and appendicular bone tumors.

Frontiers in veterinary science
2023

Renal Riddles Unveiled: Decoding Homogeneous Kidney Enlargement in Multiple Myeloma.

Cureus
2023

Case report: Corpectomy and iliac crest bone autograft as treatment for a vertebral plasma cell tumor in a dachshund dog.

Frontiers in veterinary science
2024

Solitary plasmacytoma of mandible: A case report.

Radiology case reports
2023

Myocardial plasma cell tumor with intratumoral amyloidosis in a dog.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology
2024

Respiratory Distress Caused by Neoplastic Upper Respiratory Tract Obstructions in 2 Pet Rats (Rattus norvegicus domestica).

Topics in companion animal medicine
2023

Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022.

Healthcare (Basel, Switzerland)
2023

Soft Tissue Mass Extramedullary Plasmacytoma Following Radiation Therapy for Solitary Bone Plasmacytoma.

Cureus
2023

Clinical and Laboratory Characteristics of IgM Primary Plasma Cell Leukemia.

Clinical laboratory
2024

Zinc Oxide Nanoparticles Trigger Autophagy in the Human Multiple Myeloma Cell Line RPMI8226: an In Vitro Study.

Biological trace element research
2023

A case report of POEMS syndrome with lower limb numbness and weakness.

Asian journal of surgery
2023

Solitary Extramedullary Plasmacytoma of the Head and Neck: A Report of Three Cases Treated With Curative Radiotherapy and a Review of the Dose-Control Relationship.

Cureus
2023

Solitary Plasmacytoma in the Calcaneus.

Cureus
2023

A Patient with Synchronous Gallbladder and Bone Plasmacytoma.

Diagnostics (Basel, Switzerland)
2023

[Recent Research Progress of Extramedullary Plasmacytoma --Review].

Zhongguo shi yan xue ye xue za zhi
2023

Not Your Everyday Duodenal Ulcer: Massive Gastrointestinal Bleed Secondary to Extramedullary Plasma Cell Myeloma.

ACG case reports journal
2023

Polyneuropathy organomegaly endocrinopathy M-protein and skin changes syndrome with ascites as an early-stage manifestation: A case report.

World journal of clinical cases
2023

Diagnosis and management of extramedullary plasmacytoma in nasal cavity: Clinical experience and literature review.

Medicine
2022

Multiple Myeloma With Retroperitoneal Extramedullary Plasmacytoma Causing Renal Failure and Obstructive Shock From Inferior Vena Cava Compression: A Case Report.

Cureus
2022

Conjunctival Extramedullary Plasmacytoma in Dogs and a Cat: Clinical Characteristics and Histopathological Findings.

Animals : an open access journal from MDPI
2022

Synergistically Anti-Multiple Myeloma Effects: Flavonoid, Non-Flavonoid Polyphenols, and Bortezomib.

Biomolecules
2022

Spheno-Orbital Plasmacytoma as an Initial Presentation of Multiple Myeloma.

Brain tumor research and treatment
2022

Cholangioscopic diagnosis of hemobilia: an unusual case of left hepatic portal hypertension by plasma cell tumor.

VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy
2022

Spatial Proteomics Reveals Differences in the Cellular Architecture of Antibody-Producing CHO and Plasma Cell-Derived Cells.

Molecular & cellular proteomics : MCP
2022

Suprasellar Plasmacytoma Leading to the Diagnosis of Multiple Myeloma.

Cureus
2022

[Extramedullary plasmacytoma of the larynx:a case report].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
2022

A Rare Case of Hormone-Induced Plasma Cell Granuloma of the Gingiva.

Cureus
2022

Urinary bladder wall mass with neoplastic lymphoid cells in the urine: Diagnosis of an IgG secretory B-cell lymphoma with Bence-Jones proteinuria in a dog.

Veterinary clinical pathology
2022

Atypical multiple myeloma in 3 young dogs.

Veterinary pathology
2022

[Primary extramedullary plasma cell tumor of the right kidney: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2022

IgG4-Related Kidney Disease Associated With End-Stage Kidney Disease, Renal Pseudotumor, and Renal Vein Thrombosis.

Cureus
2022

Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells.

Frontiers in oncology
2021

Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis.

Frontiers in oncology
2021

Solitary bone plasmacytoma of spine with involvement of adjacent disc space: A case report.

Medicine
2021

Coexistence of cervical extramedullary plasmacytoma and squamous cell carcinoma: A case report.

World journal of clinical cases
2021

Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma.

Cancer science
2021

Case report of peritoneal carcinomatosis of plasma cell origin in a patient with newly diagnosed HIV: A terminal event.

AIDS research and therapy
2021

Spinal cord compression due to a solitary, bulky plasmacytoma of posterior mediastinum.

Radiology case reports
2021

Lymphoma in Psittacine Birds: A Histological and Immunohistochemical Assessment.

Veterinary pathology
2021

A rare case of primary solitary endobronchial plasmacytoma.

Thoracic cancer
2020

Magnetic Resonance Imaging Features of Extradural Spinal Neoplasia in 60 Dogs and Seven Cats.

Frontiers in veterinary science
2020

Clinical Analysis of Castleman's Disease of the Lacrimal Gland.

Journal of ophthalmology
2020

Super-Enhancer Associated Five-Gene Risk Score Model Predicts Overall Survival in Multiple Myeloma Patients.

Frontiers in cell and developmental biology
2020

Mouse tumor susceptibility genes identify drug combinations for multiple myeloma.

Journal of cancer metastasis and treatment
2020

Primary extramedullary plasmacytoma of the eyelid conjunctiva - A case report and review of the literature.

Annals of medicine and surgery (2012)
2020

Quantification by Ultrafiltration and Immunofixation Electrophoresis Testing for Monoclonal Serum Free Light Chains.

Laboratory medicine
2021

Long non-coding RNA PVT1 regulates the migration of hepatocellular carcinoma HepG2 cells via miR-3619-5p/MKL1 axis.

Bosnian journal of basic medical sciences
2020

Clinical Features of Head and Neck Solitary Extramedullary Plasmacytoma in Taiwan.

In vivo (Athens, Greece)
2019

Plasma cell leukemia with plasmablastic morphology in a dog.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
2019

Primary plasmablastic plasmacytoma in the stomach of an immunocompetent adult: A case report.

Medicine
2018

Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma.

Journal of translational medicine
2018

Total En Bloc Spondylectomy for Lumbar Spinal Tumors by Paraspinal Approach.

World neurosurgery
2018

Tonsillar plasmacytoma in a dog.

The Canadian veterinary journal = La revue veterinaire canadienne
2018

Solitary plasmacytoma of the jaws: therapeutical considerations and prognosis based on a case reports systematic survey.

Brazilian journal of otorhinolaryngology
2018

A Case of Concurrent Gastric and Pancreatic Plasmacytomas in a Patient With Multiple Myeloma: An Extremely Rare Entity.

Journal of investigative medicine high impact case reports
2018

Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance.

International journal of molecular sciences
2018

Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response.

Oncotarget
2018

Targeting MYC in multiple myeloma.

Leukemia
2018

Immunohistochemical Labeling of Multiple Myeloma Oncogene 1/Interferon Regulatory Factor 4 (MUM1/IRF-4) in Canine Cutaneous Histiocytoma.

Veterinary pathology
2018

Anaplastic plasmacytoma: a rare tumor presenting as a pathological fracture in a younger adult.

Skeletal radiology
2018

Intravascular neoplastic cells in canine cutaneous plasmacytomas.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
2017

Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection.

European journal of haematology
2017

Current treatment options of T cell-associated immunotherapy in multiple myeloma.

Clinical and experimental medicine
2017

EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.

Oncotarget
2016

Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation.

Case reports in oncological medicine
2017

Proceedings of the 2016 National Toxicology Program Satellite Symposium.

Toxicologic pathology
2016

Cytology of plasma cell rich effusion in cases of plasma cell neoplasm.

Journal of cytology
2016

Revisiting IL-6 antagonism in multiple myeloma.

Critical reviews in oncology/hematology
2015

Plasmacytoma to the Axis Mimicking Metastatic Paraganglioma: Circumferential Reconstruction via Posterior Approach.

Korean Journal of Spine
2015

Resident Rounds: Part III--Case Report: Metastatic Multiple Myeloma.

Journal of drugs in dermatology : JDD
2015

Non-secreting multiple myeloma switches to IgD of lamda type: a case report and review of literature.

International journal of clinical and experimental medicine
2016

Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients.

Oncotarget
2015

Bone formation following lenalidomide-dexamethasone combination therapy in cases of multiple myeloma refractory to high-dose chemotherapy with bortezomib and autologous peripheral blood stem cell transplantation: report of a case and review of the literature.

International journal of clinical and experimental pathology
2015

Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma.

Therapeutics and clinical risk management
2015

Osseous plasma cell neoplasm of the mandible for initial diagnosis of multiple myeloma: case report and literature review.

Journal of maxillofacial and oral surgery
2015

The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Oncogene

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Tumor de plasmócitos.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Tumor de plasmócitos e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

Trata-se da proliferação anormal e descontrolada de plasmócitos, células do sistema imunológico que produzem anticorpos. Essa categoria abrange quadros como mieloma múltiplo, plasmocitoma e leucemia de plasmócitos.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

8 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. Conjunctival plasmacytoma: A case study.
    Archivos de la Sociedad Espanola de Oftalmologia2026PMID 41461288
  2. ORPHA:98282
    Orphanet
  3. GARD:19440
    GARD (NIH)
  4. Q18557283
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Tumor de plasmócitos. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/tumor-de-plasmocitos

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Tumor de plasmócitos

ORPHA:98282 · MONDO:0004959
Ensaios
94 ativos
MedGen
UMLS
C1136084
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Rara